Tilapia lake virus vaccines
AssigneesThe State of Israel, Ministry of Agriculture & Rural Developement, Kimron Veterinary Institute, Ramot at Tel-Aviv University Ltd.
InventorsEran Bacharach, Avi Eldar
Life of this patent
Estimating the term…
Abstract
The present invention relates to vaccine compositions comprising attenuated strain of Tilapia Lake Virus (TiLV) for protecting tilapia fish against infection by (TiLV). The invention also relates to methods for using the vaccines to protect tilapines from TiLV-induced disease.
Claims20
A vaccine composition comprising an attenuated strain of Tilapia Lake Virus (TiLV) for protecting tilapia fish against infection by TiLV.
An isolated TiLV deposited at the Collection Nationale de Cultures de Microorganismes (CNCM) of Institut Pasteur (France), under the depository accession number CNCM I-4817.
A method for immunizing tilapia fish against TiLV infection comprising administrating to said fish a vaccine composition comprising an attenuated strain of TiLV in an amount sufficient to induce immunity to subsequent infection by TiLV.
Dependencies are inferred from the claim text.